Dr. Ryan Saadi Commends Individuals Who Dedicate Time to Public Service, and Congratulates Mayor Victor Sordillo on His Induction Into the NJ League of Municipalities Hall of Fame
05 Diciembre 2024 - 10:03AM
Dr. Ryan Saadi, CEO of Tevogen Bio (“Tevogen” or “Tevogen Bio
Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty
immunotherapy biotech developing off-the-shelf, genetically
unmodified T cell therapeutics to treat infectious disease and
cancers, congratulates Board Member, Victor Sordillo PE, CSP, MBA,
as he was inducted into The New Jersey League of Municipalities
Hall of Fame this month.
Mayor Sordillo was inducted into the Hall of Fame for his
dedicated tenure of 24 years of continuous service as a Warren
Township Committee Member. As an elected official, Mayor Sordillo
served the community by leading the municipal government, providing
oversight to the township’s operations, and implementing policies
for the public good, essentially working for the benefit of the
citizens he represents.
“Mayor Sordillo exemplifies the qualities of a dedicated public
servant, making personal sacrifices to answer a call that many shy
away from. While policy debates are essential and differing
perspectives form the bedrock of democracy, such discussions are
incomplete without acknowledging the personal commitments and
sacrifices made by leaders like Mayor Sordillo. We extend our
deepest gratitude and congratulations on your remarkable service.”
said Ryan Saadi, MD, MPH, Tevogen Bio’s Chief Executive
Officer.
“It has been an honor to serve the residents of Warren and be
part of a very high performing team of committee people. During our
tenure, we built a new library, a new town hall, extensive youth
facilities including the football complex, playgrounds, and
basketball courts; and purchased around 1,000 acres of open space
which includes the Wagner Farm. This was accomplished while
maintaining a AAA bond rating and having one tenth of the long-term
debt allowable by the State of NJ.” said Mayor Sordillo.
Former New Jersey Governor Don DeFrancesco and current State
Senator John Bramnick recognized Warren Township and its
leadership, both having said that the Township is a model for the
State and one of the best places to live. During the Mayor’s term,
Warren was voted by Money magazine as the sixth best place to live
in America; and again by New Jersey Monthly, as the second-best
place to live in Central NJ.
Mayor Sordillo will be honored along with Gary DiNardo, Carolann
Garafola, and the late Frank Salvato during an event next week.
About Tevogen Bio
Tevogen is a clinical-stage specialty immunotherapy company
harnessing one of nature’s most powerful immunological weapons,
CD8+ cytotoxic T lymphocytes, to develop off-the-shelf, genetically
unmodified precision T cell therapies for the treatment of
infectious diseases, cancers, and neurological disorders, aiming to
address the significant unmet needs of large patient populations.
Tevogen Leadership believes that sustainability and commercial
success in the current era of healthcare rely on ensuring patient
accessibility through advanced science and innovative business
models. Tevogen has reported positive safety data from its
proof-of-concept clinical trial, and its key intellectual property
assets are wholly owned by the company, not subject to any
third-party licensing agreements. These assets include three
granted patents, nine pending US and twelve ex-US pending patents,
two of which are related to artificial intelligence.
Tevogen is driven by a team of highly experienced industry
leaders and distinguished scientists with drug development and
global product launch experience. Tevogen’s leadership believes
that accessible personalized therapeutics are the next frontier of
medicine, and that disruptive business models are required to
sustain medical innovation.
Contacts
Tevogen Bio CommunicationsT: 1 877 TEVOGEN, Ext 701
Communications@Tevogen.com
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/5f951b9e-3708-4f78-994d-b66061cc1524
Tevogen Bio (NASDAQ:TVGN)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024
Tevogen Bio (NASDAQ:TVGN)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024